Eaze Inc., California's premier legal cannabis delivery service, is excited to announce it has successfully raised $10 million in its latest funding round. Known for its commitment to providing convenience and accessibility, Eaze has revolutionized the way consumers access cannabis, delivering over seven million orders to date. This significant infusion of capital will be directed toward expanding Eaze's operations and enhancing its innovative Momentum business accelerator and Social Equity Partners Program. Through these initiatives, Eaze aims to empower underrepresented communities and promote a more diverse and sustainable cannabis industry. The funds will also support technology upgrades and marketing efforts, ensuring that Eaze continues to lead in delivering a seamless, user-friendly experience for its customers. "Our mission has always been to break down barriers to access and cultivate community – this funding will allow us to do just that on a larger scale," said Eaze CEO, in a statement highlighting the company's forward-thinking vision. As the cannabis industry continues to thrive amidst changing regulations, Eaze is poised to remain at the forefront of this transformative market, fostering a culture of inclusivity and responsibility. With an ever-expanding customer base and a commitment to social equity, Eaze is more than just a delivery service; it stands as a beacon of hope and progress in the cannabis landscape. For more information about Eaze and its initiatives, visit eaze.com.
Eaze Inc Secures $10 Million in Series B Funding to Revolutionize Cannabis Delivery Experience
Get the full Eaze Inc company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
CereVasc
CereVasc, Inc. is developing the eShunt System for the treatment of patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults.
$85.0M Series c
today
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today
Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today
Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today
Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  ONA Therapeutics Spain | Series b | $86.6M | today |
| 2 |  GR3N SA Switzerland | Series b | $15.5M | 1d ago |
| 3 |  701x United States | Series b | $10.0M | 1d ago |
| 4 |  Wordsmith AI United States | Series b | $70.0M | 1d ago |
| 5 |  MJOLNIR SPACEWORKS Japan | Series b | $11.1M | 2d ago |